QUAMED Learning Course 2 Inspections

Do you want to become a GSDP Auditor and help importers, wholesalers, and national supply agencies ensure product quality?  QUAMED Learning presents the first-ever eLearning course for pharmaceutical professionals that focuses on developing skills needed by a GSDP auditor. The course is funded by the Bureau of Humanitarian Affairs of USAID and is ‘FREE’ for ...

Know Quamed Learning

QUAMED Learning is the premier learning platform on pharmaceutical quality assurance. The platform is developed with support from the USAID – Bureau for Humanitarian Assistance and hosts self-paced eLearning courses, a helpdesk with resources and a global community of professionals. Join this webinar on 22nd August organized by QUAMED to provide information on how you can improve your ...

Assessing Essential Medicine Quality in Enugu and Anambra, Nigeria

This study examined 260 samples of 13 essential medicines in Enugu and Anambra, Nigeria, revealing that 25.4% did not meet USP 42 standards. Dexamethasone tablets had a 95% failure rate, and noncommunicable disease drugs showed higher non-compliance (21.2%) than anti-infectives (17.6%). OOS rates were similar between licensed vendors (25.2%) and market vendors (25.5%), with only ...

Alarming Findings on Essential Medicine Quality in Nepal’s Public Health Facilities

This an interesting study for those organizations that are supporting health facilities in Nepal. Assessment of Essential Medicine Quality in Nepal’s Public Health Facilities: Alarming Findings! A nationwide study reveals concerning results regarding the quality of essential medicines in Nepal’s public health care facilities. Only 13% of facilities followed storage guidelines, and 37 batches out ...

QUAMED Online Learning Platform

As previously announced, Quamed is working on an online learning platform with the aim to increase the knowledge and capability around the quality assurance of pharmaceuticals for staff working with public & private pharmaceutical suppliers and the national regulatory authorities. The development of this platform is supported by the Bureau of Humanitarian Affairs of USAID. ...

Quamed logo Quality Medicine for all

QUAMED joins the Global Health Supplies discussion on Nov 28th 2022

The QUAMED director Ed Vreeke participates in the Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen ( 28 November-01 December 2022). The title of the meeting is Global Health Supplies: Paradigm Shifts in Market Authorization, Procurement and Supply Chains Approach. We are represented to learn more about the quality assurance systems of suppliers and the QA needs of procurers ...

PAHO GSDP & MQAS Training Program

QUAMED has signed a contract with PAHO to develop a GSDP (Good Storage and Distribution Practices) and MQAS (Model Quality Assurance Systems for Procurement Agencies) training program. To develop this training we are partnering with the Institute of Tropical Medicine and with the University of Western Cape as well as with individual technical specialists. The GSDP/MQAS training ...

ECOWAS Epidemiology Network

The ECOWAS has launched its 2018-2019 West Africa Epidemiology Network on Drug Use (WENDU) Report with an aim at effectively fighting illicit drug use and trafficking in the sub-region. This report contains statistics and trends of illicit drug supply and drug use in the region and will help the ECOWAS member states in developing programmes, ...

The quality of Cardiovascular medicines

Today, there is a growing need for good quality cardiovascular medicines and devices for the prevention and management of the ever-growing threats of cardiovascular diseases(CVDs) globally. That is why the objective of this study was to review the available literature on SF cardiovascular medicines/devices, with a focus on prevalence studies to discuss their impacts on ...

Fighting poor quality health products in times of Covid-19 and beyond: the need for a multi-stakeholder approach

World Health Organization (WHO) estimates from 2017 indicates that 10.5% of medical products available in low- and middle-income countries (LMICs) are “substandard or falsified” (SF). Substandard health products are approved by the national regulators, but they do not comply with adequate standards due to undetected errors, negligence, or poor practice in manufacturing, transportation, or storage. ...

Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.